4//SEC Filing
Breitfeld Philip P. 4
Accession 0001628280-22-026398
CIK 0000771856other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 2:25 PM ET
Size
8.6 KB
Accession
0001628280-22-026398
Insider Transaction Report
Form 4
Breitfeld Philip P.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-10-12$3.21/sh+8,333$26,749→ 18,200 total - Tax Payment
Common Stock
2022-10-12$7.51/sh−3,562$26,751→ 14,638 total - Exercise/Conversion
Option to purchase Common Stock
2022-10-12−8,333→ 0 totalExercise: $3.21Exp: 2022-10-31→ Common Stock (8,333 underlying)
Footnotes (2)
- [F1]Represents a "net exercise" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022.
- [F2]The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018
Documents
Issuer
CHAMPIONS ONCOLOGY, INC.
CIK 0000771856
Entity typeother
Related Parties
1- filerCIK 0001690133
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 2:25 PM ET
- Size
- 8.6 KB